
The chemical zzso of low molecular weight zzso with zzso zzso was previously designed to offer zzso activity while minimizing the zzso zzso In the present study, we found that the systemic administration of zzso in zzso could substantially enhance tumor zzso targeting and zzso zzso Moreover, we found that zzso of zzso with zzso zzso acid zzso a zzso zzso zzso in zzso could provide synergistic zzso zzso zzso zzso was formulated by zzso zzso inside zzso zzso followed by zzso of zzso charged zzso onto the zzso surfaces of zzso zzso zzso zzso zzso was positively charged with a mean diameter of zzso zzso and stable in zzso The zzso form of zzso could alter its zzso and zzso Compared to the free form of zzso zzso in the zzso showed zzso higher mean residence time, and higher tumor zzso zzso after its intravenous zzso zzso zzso showed highest zzso efficacy in zzso mice, compared to zzso zzso and sequential zzso of zzso and zzso zzso with the enhanced zzso effect, the reduction of abnormal vessels in the tumor site was also the highest in the zzso zzso zzso These results suggested the potential of zzso zzso for enhanced tumor zzso zzso and the importance of zzso zzso with a zzso zzso inhibitor for zzso zzso zzso 

